Literature DB >> 405320

Lipopolysaccharide serotyping of Neisseria meningitidis by hemagglutination inhibition.

R E Mandrell, W D Zollinger.   

Abstract

The method of hemagglutination inhibition was used to investigate the antigenic diversity of lipopolysaccharide (LPS) from Neisseria meningitidis and to develop a serotyping systems based on this antigen. The system uses outer membrane complex prepared by a simple extraction procedure to inhibit homologous hemagglutination reactions involving sheep erythrocytes sensitized with purified LPS and rabbit antiserum raised to whole meningococci. Antisera with specificity for eight different LPS determinants were used as typing sera to serotype a cross section of 67 meningococcal strains. Only two strains (both group A) were not typable with the eight sera, and most strains had more than one type. Comparison of LPS type and bactericidal serotype suggests that the LPS and protein serotypes are independent serological markers.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 405320      PMCID: PMC420975          DOI: 10.1128/iai.16.2.471-475.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  9 in total

1.  New Classification of Neisseria meningitidis by Means of Bactericidal Reactions.

Authors:  R Gold; F A Wyle
Journal:  Infect Immun       Date:  1970-05       Impact factor: 3.441

2.  Antigenic specificity of bactericidal antibodies in antisera to Neisseria meningitidis.

Authors:  D L Kasper; J L Winkelhake; B L Brandt; M S Artenstein
Journal:  J Infect Dis       Date:  1973-04       Impact factor: 5.226

3.  Classification of Neisseria meningitidis group B into distinct serotypes. I. Serological typing by a microbactericidal method.

Authors:  C E Frasch; S S Chapman
Journal:  Infect Immun       Date:  1972-01       Impact factor: 3.441

4.  Classification of Neisseria meningitidis group B into distinct serotypes. II. Extraction of type-specific antigens for serotyping by precipitin techniques.

Authors:  C E Frasch; S S Chapman
Journal:  Infect Immun       Date:  1972-08       Impact factor: 3.441

5.  Bactericidal antibody assay using 14 C-labeled Neisseria meningitidis.

Authors:  D L Kasper; F A Wyle; S B Formal
Journal:  Proc Soc Exp Biol Med       Date:  1972-04

6.  Isolation and characterization of a native cell wall complex from Neisseria meningitidis.

Authors:  W D Zollinger; D L Kasper; B J Veltri; M S Artenstein
Journal:  Infect Immun       Date:  1972-11       Impact factor: 3.441

7.  Role of meningococcal endotoxin in meningococcal purpura.

Authors:  C E Davis; K Arnold
Journal:  J Exp Med       Date:  1974-07-01       Impact factor: 14.307

8.  Human antibody response to three meningococcal outer membrane antigens: comparison by specific hemagglutination assays.

Authors:  W D Zollinger; C L Pennington; M S Artenstein
Journal:  Infect Immun       Date:  1974-11       Impact factor: 3.441

9.  An outer membrane protein of Neisseria meningitidis group B responsible for serotype specificity.

Authors:  C E Frasch; E C Gotschlich
Journal:  J Exp Med       Date:  1974-07-01       Impact factor: 14.307

  9 in total
  46 in total

1.  Outer membrane antigens of Neisseria meningitidis group B serotype 2 studied by crossed immunoelectrophoresis.

Authors:  G E Hoff; C E Frasch
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

Review 2.  Phase and antigenic variation in bacteria.

Authors:  Marjan W van der Woude; Andreas J Bäumler
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

3.  Immunological Characterization of Pectinatus cerevisiophilus Strains.

Authors:  A Haikara
Journal:  Appl Environ Microbiol       Date:  1983-11       Impact factor: 4.792

4.  Genetic analysis of a meningococcal population based on polymorphism of the pilA-pilB locus: a molecular approach for meningococcal epidemiology.

Authors:  M Guibourdenche; D Giorgini; A Guèye; M Larribe; J Y Riou; M K Taha
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

5.  Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease.

Authors:  D A Caugant; L O Frøholm; K Bøvre; E Holten; C E Frasch; L F Mocca; W D Zollinger; R K Selander
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

6.  Antigenic and physical diversity of Neisseria gonorrhoeae lipooligosaccharides.

Authors:  R Mandrell; H Schneider; M Apicella; W Zollinger; P A Rice; J M Griffiss
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

7.  Ability of gonococcal and meningococcal lipooligosaccharides to clot Limulus amebocyte lysate.

Authors:  R I Roth; R Yamasaki; R E Mandrell; J M Griffiss
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

8.  Humoral immune response to the class 3 outer membrane protein during the course of meningococcal disease.

Authors:  H K Guttormsen; L M Wetzler; A Naess
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

9.  Production and characterization of monoclonal antibodies to type 8 lipooligosaccharide of Neisseria meningitidis.

Authors:  X X Gu; C M Tsai; A B Karpas
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

10.  Immunological cross-reaction between a naturally occurring galactan, agarose, and an LPS locus for immune lysis of Neisseria meningitidis by human sera.

Authors:  J M Griffiss; D K Goroff
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.